Clinical Trial Update: Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigates the effects of oral glucose and teduglutide on plasma lipoproteins in individuals with hyperlipidemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemias

Drugs mentioned

• Oral glucose (glucose)
• Teduglutide (teduglutide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hyperlipidemias | Phase 2, Phase 3 | Status: UNKNOWN